Results 111 to 120 of about 20,646 (210)

Letrozole induced Necrotizing Cutaneous Vasculitis: A Rare Entity

Clinical Dermatology Review
Cutaneous small vessel vasculitis (CSVV) could be due to varied etiologies of which drug induced CSVV is a prime cause. It commonly presents as purpura but necrotizing lesions can be an uncommon presentation of the disease.
Liza Mohapatra, Soumya Surath Panda, Manoj Kumar Nayak, Kallolinee Samal   +3 more
doaj   +1 more source

Letrozole Determination by Capillary Zone Electrophoresis and UV Spectrophotometry Methods

, 2017
Objective: Letrozole is a highly potent oral nonsteroidal aromatase inhibitor triazole derivative. The aim of this study was to quantify letrozole from bulk, pharmaceutical formulation, and spiked urine samples by developing a simple, rapid and cost ...
Nicoleta Todoran, Aura Rusu, Camil-Eugen Vari, Maria-Alexandra Sbanca   +3 more
core   +1 more source

Efficacy of melatonin and letrozole combination therapy compared to letrozole alone in the treatment of symptomatic endometrioma in infertile women

Background: Endometriosis is an estrogen-driven inflammatory condition involving endometrial tissue growth outside the uterus. Letrozole, an aromatase inhibitor, lowers estrogen levels to reduce pain and lesion size.
Banu, Jesmine, Ishrat, Shakeela, Jahan, Nishat, Khatun, M. Sumyara, Islam, M. Ariful, Islam, Tahmida, Islam, Aminul, Deeba, Farzana   +7 more
core   +1 more source

Preclinical modeling of endocrine response: a combination therapy approach with the ERβ agonist, diarryl propionitrile and letrozole restores sensitivity to letrozole-resistant breast cancer cells.

, 2009
Abstract #17 The majority of breast cancer patients are postmenopausal women with estrogen receptor-positive (ER+) tumors. Approximately 66% of breast carcinomas contain aromatase. Aromatase inhibitors are proving to be more effective than
SR Saha, RP Perla, RR Tekmal, P Veerapaneni, NB Kirma, HB Nair, DB Evans, B Santhamma, AH Brodie, AK Joseph, R Jayarajan   +10 more
core   +1 more source

Letrozole: A Steroid-Free Estrous Synchronization Method

, 2018
Most bovine estrous synchronization protocols utilize progesterone plus estrogen to control ovulation timing. A drug that inhibits estrogen production (Letrozole) may be an alternative, steroid-free synchronization method (not yet commercially available).
Kurz, Scott G., Davis, John S., Wood, Jennifer R., Cupp, Andrea S., Romereim, Sarah M., Abedal-Majed, Mohamed A., Majed, Bergman, Jeffrey W., Tenley, Sarah C.   +7 more
core  

The Efficacy of Letrozole Co-Treatment in an Antagonist Protocol for Women with Polycystic Ovary Syndrome Undergoing IVF: A Retrospective Study

Jing Lin,1 Fenglu Wu,2 Yanwen Zhu,2 Qianqian Zhu,2 Tong Du,2 Jiaying Lin2 1Center for Reproductive Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Assisted Reproduction ...
Zhu Y, Du T, Lin J, Wu F, Zhu Q
core  

Letrozole::advancing hormone therapy in breast cancer

, 2012
Letrozole is a type 2 aromatase inhibitor, which reduces availability of estrogen in postmenopausal women, thereby decreasing its ability to stimulate breast cancer cells.
Armstrong, A.C., Wardley, A.M., Lee, R.J.; id_orcid   +2 more
core   +1 more source

Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study

Journal of Human Reproductive Sciences
Background: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response.
Pratyasha Peepal, Padmalaya Thakur, Anubhuti Patel, Jyotiranjan Sahoo, Sujata Pradhan, Manisha Sahu   +5 more
doaj   +1 more source

Novel approaches for neuroprotection: Focus on neurodegenerative and ischemic central nervous system diseases

Neuroprotection, Volume 4, Issue 2, Page 95-98, June 2026.
Shen Li, Xunming Ji, Piotr Walczak, Johannes Boltze   +3 more
wiley   +1 more source